Cargando…
From Research to Policy: The WHO Experience With Developing Guidelines on the Potential Risk of HIV Acquisition and Progestogen-Only Contraception Use
To develop guidance for women at high risk of HIV, WHO carefully considered the risks of maternal morbidity and mortality from unintended pregnancy against possible increased risk of HIV acquisition with injectable use. Among the many challenges: (1) balancing timeliness of changing the guidance aga...
Autores principales: | Han, Leo, Patil, Eva, Kidula, Nancy, Lyn Gaffield, Mary, Steyn, Petrus S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Global Health: Science and Practice
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752602/ https://www.ncbi.nlm.nih.gov/pubmed/29284693 http://dx.doi.org/10.9745/GHSP-D-17-00278 |
Ejemplares similares
-
Hormonal contraception in women with migraine: is progestogen-only contraception a better choice?
por: Nappi, Rossella E, et al.
Publicado: (2013) -
Progestogen-only oral contraceptives: Number 4 - April 2022
por: Machado, Rogério Bonassi, et al.
Publicado: (2022) -
Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women()()
por: Heffron, Renee, et al.
Publicado: (2019) -
Effectiveness and acceptability of progestogens in combined oral contraceptives – a systematic review
por: Kulier, Regina, et al.
Publicado: (2004) -
The clinical relevance of progestogens in hormonal contraception: Present status and future developments
por: Regidor, Pedro-Antonio
Publicado: (2018)